Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global artificial intelligence in medical imaging market was valued at USD 1.62 Billion in 2025. It is poised to grow at a CAGR of 22.50% during the forecast period of 2026-2035, and reach USD 12.33 Billion by 2035. The market growth is driven by rising demand for accurate diagnostics and workflow efficiency, driving adoption of AI solutions, particularly CT scan AI, in medical imaging.
Base Year
Historical Period
Forecast Period
In March 2026, Philips’ AI-enhanced Rembra CT launch and 2025 acquisitions like Gleamer drive CT scan AI adoption worldwide.
In October 2025, Gleamer acquired Pixyl and Caerus Medical, expanding AI-powered MRI reconstruction and multimodal imaging capabilities globally.
In February 2026, Philips and ACTREC Tata Memorial partnered to strengthen early cancer detection in India using advanced CT scan AI and spectral CT imaging.
Compound Annual Growth Rate
22.5%
Value in USD Billion
2026-2035
*this image is indicative*
Artificial Intelligence (AI) is transforming medical imaging by improving diagnostic accuracy, accelerating image analysis, and enabling personalized treatment planning. AI applications like CT scan AI, MRI reconstruction, and image segmentation streamline radiology workflow, reduce human errors, and enhance detection of subtle abnormalities. Advanced technologies, including deep learning imaging and noise reduction AI, are turning the game by making imaging faster, more precise, and increasingly predictive in patient care. The market reached a value of approximately USD 1.62 Billion in 2025.
Strategic Innovations and AI Adoption in Medical Imaging
The market is being driven by rapid adoption of advanced AI technologies in diagnostics and workflow. In March 2026, Philips unveiled the AI-integrated Rembra CT platform at the European Congress of Radiology, offering high-resolution, dose-efficient scans with deep learning imaging enhancements. FDA clearances and strategic acquisitions, including Coreline Soft in 2025 and Gleamer’s purchase of Pixyl and Caerus Medical, are further accelerating adoption of CT scan AI and MRI reconstruction globally.
Key trends shaping the market include AI-driven imaging, MRI reconstruction, workflow automation, and advanced diagnostics.
Strategic Acquisitions Expanding AI in Medical Imaging
Growing demand for faster, more accurate diagnostics is driving AI adoption in medical imaging. For instance, in October 2025, Gleamer acquired Pixyl and Caerus Medical to strengthen its AI-powered MRI capabilities. This strategic move expands multimodal imaging solutions, meeting rising clinical demand for advanced MRI imaging technology. By integrating cutting-edge AI technologies, the company enhances diagnostic accuracy, workflow efficiency, and early disease detection, reflecting a broader trend of consolidation and innovation driving growth in the market.
Market Breakup by Component
Market Breakup by Modality
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
CT scan Expected to Dominate the Market Segment by Modalities
Based on modalities, the CT scan segment held the largest market share of over 34% during the historical period. This dominance is attributed to widespread adoption of AI-enhanced imaging solutions that improve diagnostic accuracy and speed. Technologies such as CT scan AI enable faster image processing, early disease detection, and improved clinical outcomes, making CT imaging a critical component in modern radiology practices globally.
North America dominated the global industry during the historical period, accounting for the largest revenue share of approximately 43%. The region benefits from advanced healthcare infrastructure, high investment in digital health, and early adoption of innovative technologies. Increasing integration of AI solutions, particularly in radiology workflow, is enhancing operational efficiency, reducing diagnostic errors, and supporting the region’s continued leadership in the medical imaging market.
The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
GE HealthCare, a global leader in medical technology and digital solutions, has significantly enhanced its role in the artificial intelligence in medical imaging market. In January 2025, it announced a strategic collaboration with Sutter Health. The multi-year partnership focuses on deploying advanced AI-powered imaging systems, including AIR™ Recon DL, Omni Legend PET/CT, StarGuide SPECT/CT, and Caption AI ultrasound, across more than 300 facilities, improving diagnostic accuracy, workflow efficiency, and patient access.
Microsoft Corporation is advancing artificial intelligence in medical imaging market through Project InnerEye, a research initiative under Microsoft Health Futures. The project focuses on AI-powered tools for the automated analysis of 3D medical images using Azure Machine Learning. Collaborations with institutions like Cambridge University Hospitals have led to innovations such as OSAIRIS, a cloud-based AI system that significantly reduces radiotherapy planning time, enhancing diagnostic efficiency and patient outcomes.
TEMPUS is a technology-driven precision medicine company that plays a significant role in the market. It offers AI-enabled imaging solutions such as Tempus Pixel, tailored for oncology, radiology, lung, breast, and cardiac care. These solutions utilize advanced algorithms for automated lesion segmentation, quantification, and longitudinal tracking, enhancing diagnostic accuracy and clinical decision-making across over 100 health systems.
Butterfly Network, Inc., a digital health company founded in 2011, is revolutionizing medical imaging through its AI-driven handheld ultrasound device, the Butterfly iQ+. In 2023, the company received FDA clearance for its AI-enabled Auto B-line Counter, designed to streamline lung assessments by using deep learning to detect B-lines in ultrasound images. This advancement strengthens Butterfly’s role in the global artificial intelligence in medical imaging market by offering faster, more accurate diagnostic tools at the point of care.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are HeartFlow, Inc., Enlitic, Inc., Canon Medical Systems Corporation, Viz.ai, Inc., EchoNous, Inc., and Exo Imaging, Inc., among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Component |
|
| Breakup by Modality |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share